Jan 10, 2024 / 05:00PM GMT
Ekaterina Knyazkova JPMorgan-Analyst
Good morning, everybody. I'm Ekaterina Knyazkova at JPMorgan and pleased to be introducing Amphastar. And from Amphastar, we have Jack Zhang, CEO; and Bill Peters, CFO, who will be doing a presentation and then we will jump into Q&A.
And with that, I will turn it over to Jack and Bill.
William Peters Amphastar Pharmaceuticals Inc-CFO
Thanks, Ekaterina, and thanks to JPMorgan for inviting us to attend. This is our first presentation here at the JPMorgan conference, so we're really happy to be here today.
I just wanted to take a moment to mention the forward-looking statements. And all of the things that we might be saying today might have some forward-looking guidance, and the forward-looking statements can be found both in our presentation, which is on our website, and also in our SEC filings online.
With that, I'll turn it back over to our CEO, Jack Zhang.
Jack Zhang Amphastar Pharmaceuticals Inc-CEO - President, Chief Scientific
Amphastar Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot